Navigation Links
Sciele Pharma Announces Successful Completion of New Sular,Formulation Clinical Trial Program

's products are marketed throughout the world by leading pharmaceutical companies. For more information, visit www.skyepharma.com.

Safe Harbor Statement

This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to materially differ from those described. Although we believe that the expectations expressed in these statements are reasonable, we cannot promise that our expectations will turn out to be correct. Our actual results could be materially different from and worse than our expectations. With respect to such forward-looking statements, we seek the protections afforded by the Private Securities Litigation Reform Act of 1995. These risks include, without limitation:

We may not attain expected revenues and earnings. If we are unsuccessful in obtaining or renewing third party payor contracts for our products, we may experience reductions in sales levels and may fail to reach anticipated sales levels. If demand for our products exceeds our initial expectations or the ability of our suppliers to provide demand-meeting quantities of product and samples, our future ability to sell these products could be adversely impacted. The potential growth rate for our promoted products may be limited by slower growth for the class of drugs to which our promoted products belong and unfavorable clinical studies about such class of drugs.

We may encounter problems in the manufacture or supply of our products, for which we depend entirely on third parties. Strong competition exists in the sale of our promoted products, which could adversely affect expected growth of our promoted products' sales or increase our costs to sell our promoted products. We may not be able to protect our competitive position for our promoted products from patent infringers. If generic competitors that compete with any of our products are introduced, o
'"/>




Page: 1 2 3 4

Related medicine technology :

1. SkyePharma and Sciele Pharma Announce Successful Completion of New Sular Formulation Clinical Trial Programme
2. Sygnis Pharma AG announces date for presentation of clinical results
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:11/22/2014)... , Nov. 21, 2014  CytoSorbents Corporation (OTCQB: ... European Union approved CytoSorb® cytokine adsorber to treat ... the Beacon of Light Award at last night,s ... Dr. Phillip Chan , Chief ... honor to be recognized by the New Jersey ...
(Date:11/22/2014)... Statistics released from a number of organizations ... during the holidays, beginning with Thanksgiving eve, which is ... The data, highlighted in an Infographic ... of their annual Sober Days for the Holidays ... drinking and increased rates of DUI injuries and deaths ...
(Date:11/22/2014)... Nov. 21, 2014 Research and Markets  has ... Drug Industry Report, 2014-2017" report to their offering. ... The Chinese recombinant protein drug market has been expanding ... ability and the like. During 2005-2013, sales of recombinant ... a CAGR of 19.1%, and it is projected that ...
Breaking Medicine Technology:CytoSorbents Wins Beacon of Light Award 2CytoSorbents Wins Beacon of Light Award 3CytoSorbents Wins Beacon of Light Award 4Alarming Stats Show Holiday Drinking an Issue for Many 2China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3
... HASCO Medical, Inc. (OTC Bulletin Board: HASC ... serves patients in Alabama, Florida, and Mississippi, today announced ... subsidiary of HASCO Medical, has signed an agreement with ... of the agreement, SMM will be providing high-end rehabilitation chairs ...
... NEW YORK, Jan. 13, 2011 Reportlinker.com announces ... in its catalogue: Merck & ... http://www.reportlinker.com/p074950/Merck--Co-Inc-PharmaVitae-Profile.html IntroductionThis analysis examines ... Co. in the prescription pharmaceutical sector. The profile ...
Cached Medicine Technology:HASCO Medical Signs Agreement With the State of Alabama 2Reportlinker Adds Merck & Co., Inc.: PharmaVitae Profile 2
(Date:11/24/2014)... 2014 The Healthy Skin Care Journal, ... affordable skin care products, recently announced its launch. Located ... a wide variety of articles, tips, and evaluations about ... skincare alternatives. , According to Emily Lataille, the website’s ... includes thoroughly researched reviews, tips for the skin, and ...
(Date:11/24/2014)... Alexandria, VA (PRWEB) November 24, 2014 ... will hold its 12th annual International Symposium on Malignant ... in Bethesda, Maryland. Daytime conference sessions will take place ... in Bethesda, while dinners, including a community dinner and ... Regency Bethesda. , Sessions will cover a range of ...
(Date:11/24/2014)... November 24, 2014 Abington Health ... MD has joined The Neurology Group and has ... Sclerosis Center. , A graduate of Vinnica Medical ... at Albert Einstein Medical Center in Philadelphia and completed ... Multiple Sclerosis Center at Weill Cornell Medical College. Ternopolska ...
(Date:11/24/2014)... A new sports massage technique available ... and massage therapy provider, announced it newest massage ... newest sports massage is a fast-acting, “to-the-point” ... sports massage and ESM is that ESM has ... "reset button,” and ESM can increase flexibility, elasticity, ...
(Date:11/24/2014)... November 24, 2014 Recently, SweetDressy.com, a ... unveiled its new collection of 2014 Evening Dresses. All ... According to the company’s marketing manager, the special offer ... for more. , Sweetdressy.com has been working well ... to unveil the latest designs. Their new dresses may ...
Breaking Medicine News(10 mins):Health News:Skin Care Advice Blog The Healthy Skin Care Journal Now Accessible to the Public 2Health News:2015 International Symposium on Malignant Mesothelioma Will Take Place at the National Institutes of Health Campus 2Health News:2015 International Symposium on Malignant Mesothelioma Will Take Place at the National Institutes of Health Campus 3Health News:Nataliya Ternopolska Named Associate Medical Director of Abington Health’s Multiple Sclerosis Center 2Health News:Sports Massage in London by Massaggi Presents New Technique to Reset Muscles, Rapidly Eliminate Pain 2Health News:Sports Massage in London by Massaggi Presents New Technique to Reset Muscles, Rapidly Eliminate Pain 3Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2
... able to delay the onset of the disease or even ... to a study presented today at the annual meeting of ... the results of our study, participating in a high-impact activity, ... least three times a week appears associated with more degenerated ...
... CHICAGO Women with a personal history of breast ... to mammography, according to a study presented today at ... America (RSNA). The American Cancer Society (ACS) guidelines ... with a known gene mutation or with a strong ...
... Institute of Neurological Disease (GIND) in San Francisco have ... a mouse model of Alzheimer,s disease (AD). Humans with ... have abnormally low levels of an enzyme called EphB2 ... in such mice by gene therapy completely fixed their ...
... , SUNDAY, Nov. 28 (HealthDay News) -- The contents of ... nutrition, a new study shows. U.S. researchers examined the ... of 5,930 students at 152 schools. The vending machines in ... value, including chips, sodas and sweets. In elementary schools ...
... , FRIDAY, Nov. 26 (HealthDay News) -- There are a ... Friday," says a University of Delaware researcher. Black Friday, ... holiday shopping season. "If people put a lot of ... who were likely to be the misbehavers on Black Friday," ...
... FRIDAY, Nov. 26 (HealthDay News) -- If you,re told that ... reaction and carefully consider the situation, advises an expert. ... temptation to respond defensively with ,not my child., Understand that ... professor of health services at Saint Joseph,s University in Philadelphia, ...
Cached Medicine News:Health News:Light exercise may prevent osteoarthritis 2Health News:Women with personal history of breast cancer should be screened with MRI 2Health News:Gene therapy prevents memory problems in mice with Alzheimer's disease 2Health News:Parents of Bullies Urged to Open Lines of Communication 2
Inquire...
... CLOtest Rapid Urease Test is recognized by ... urease tests because of its accuracy, convenience ... Marshall, MD. who, along with Robin Warren, ... correlation between H. pylori and gastric ulcers. ...
Serim PyloriTek Test Kit detects urease activity in gastric biopsy specimens for the presumptive identification of an Helicobacter pylori infection....
... The QuickVue H.pylori gII test is a ... qualitative detection of IgG antibodies specific to ... whole blood. It utilizes a convenient, non-invasive, ... aid physicians in the diagnosis of H.pylori ...
Medicine Products: